Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00626379 · ClinicalTrials.gov registry record

Examining How Heart Disease Risk Factors Affect Healthy Aging (The Chicago Healthy Aging Study [CHAS])

A clinical trial of Cardiovascular Diseases and Coronary Disease, sponsored by Northwestern University.

Completed
Registry status
1,395
Enrollment target
1
Study location

NCT00626379: Completed study of Cardiovascular Diseases and Coronary Disease, sponsored by Northwestern University.

NCT00626379 is a study of Cardiovascular Diseases and Coronary Disease that has completed, run by Northwestern University. The registered enrollment target is 1,395 participants, below the 26,970-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00626379, a study of Cardiovascular Diseases and Coronary Disease, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
1,395 participants
Enrollment target
1
Study location

Study Summary

Heart disease is the leading cause of death in the United States and is responsible for 30% of all deaths in the United States. This study will examine how risk factors for heart disease in young and middle aged people affect people's health as they grow older.

Study Locations (1)

Illinois

  • Preventive Medicine Research Clinic - Chicago

Trial Details

FieldValue
Enrollment Target 1,395 participants
Start Date 2007-11
Est. Completion 2010-12
Northwestern University

1,209 total trials

What the finished NCT00626379 record still lists

NCT00626379 is an observational study that tracks outcomes without assigning an intervention. Its 1,395 participants enrollment target places it among the larger protocols in the corpus, below the 26,970-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (95% lower).

The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 0 interventions.

NCT00626379 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT00626379 about?

NCT00626379 is a clinical study titled "Examining How Heart Disease Risk Factors Affect Healthy Aging (The Chicago Healthy Aging Study [CHAS])". Heart disease is the leading cause of death in the United States and is responsible for 30% of all deaths in the United States. This study will examine how risk factors for heart disease in young and middle aged people affect people's health as they grow older.

What is the current status of trial NCT00626379?

This trial is currently completed. The enrollment target is 1,395 participants. The study started on 2007-11. Estimated completion is 2010-12.

What conditions does trial NCT00626379 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Coronary Disease.

Who is sponsoring clinical trial NCT00626379?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00626379 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00626379's enrollment target sits among peer trials

1,395 45th of 300 higher than 256 of 300 other Cardiovascular Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05006131 · 1,395 participants

    Pancreatic Cancer Screening for At-risk Individuals

  • NCT02205762 · 1,400 participants · Phase 2

    LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

  • NCT02445222 · 1,400 participants · Phase 3

    CAR-T Long Term Follow Up (LTFU) Study

  • NCT03145077 · 1,400 participants · NA

    Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00626379, the US trial registry maintained by the National Library of Medicine. NCT00626379 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.